Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-20

Clinical Trial Update: Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated whether mirtazapine can reduce methamphetamine use among men who have sex with men with high-risk HIV behaviors; results were posted aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • mirtazapine (mirtazapine)

Snippet

Sponsor: San Francisco Department of Public Health | Conditions: Substance Abuse, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2014-10-20